Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer

Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric cancer (GC) consists of two-drug, usually fluoropyrimidine-based, combinations, with or without the addition of biological agents. Studies of triple-drug regimens combining 5-fluorouracil (5-FU)/folini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peinert, Stefan, Grothe, Wilfried, Stein, Alexander, Müller, Lutz P., Ruessel, Joern, Voigt, Wieland, Schmoll, Hans-Joachim, Arnold, Dirk
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2010
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126013/
https://ncbi.nlm.nih.gov/pubmed/21789132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834010365061
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados